A novel EGFL7-derived peptide, E7C13, is a potent anti-tumor agent that inhibits angiogenesis in a beta 1 integrin- and thrombospondin-dependent manner Meeting Abstract


Authors: Cho, C. F.; Fung, L. A.; Nsiama, T.; Yu, L. H.; Kadam, A.; Quail, D. F.; Carmine-Simmen, K.; Pink, D.; Postovit, L. M.; Luyt, L. G.; Lewis, J. D.
Abstract Title: A novel EGFL7-derived peptide, E7C13, is a potent anti-tumor agent that inhibits angiogenesis in a beta 1 integrin- and thrombospondin-dependent manner
Meeting Title: 105th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 74
Issue: 19 Suppl.
Meeting Dates: 2014 Apr 5-9
Meeting Location: San Diego, CA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2014-10-01
Language: English
ACCESSION: WOS:000349910203282
DOI: 10.1158/1538-7445.am2014-4812
PROVIDER: wos
Notes: Meeting Abstract: 4812 -- 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 05-09, 2014 -- San Diego, CA -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Daniela Francis Quail
    13 Quail